Granata Bio is a clinical-stage biopharmaceutical company focused on reproductive health, identifying and developing fertility treatments to expand therapeutic choices and improve access for patients. Founded in 2018 and based in Duxbury, Massachusetts, the company is advancing a pivotal Phase III study of a novel gonadotropin for assisted reproductive technology.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account